Objective: to find out whether somatization disorder is equal to masked depression.
目的:了解躯体化障碍是否等同于隐匿性抑郁症。
Conclusion the therapeutic efficacy of paroxetine for somatization disorder is significant with less side effects.
结论:帕罗西汀治疗躯体化障碍疗效较好,副作用少。
Objective: To compare the efficacy and side effect of venlafax ine and doxepin in the treatment of somatization disorder.
目的:评价万拉法新对躯体化障碍的疗效和副反应。
应用推荐